392 related articles for article (PubMed ID: 12430715)
21. Immunohistochemical analysis of Marinesco bodies, using antibodies against proteins implicated in the ubiquitin-proteasome system, autophagy and aggresome formation.
Odagiri S; Tanji K; Mori F; Kakita A; Takahashi H; Kamitani T; Wakabayashi K
Neuropathology; 2012 Jun; 32(3):261-6. PubMed ID: 22118216
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
Janer A; Werner A; Takahashi-Fujigasaki J; Daret A; Fujigasaki H; Takada K; Duyckaerts C; Brice A; Dejean A; Sittler A
Hum Mol Genet; 2010 Jan; 19(1):181-95. PubMed ID: 19843541
[TBL] [Abstract][Full Text] [Related]
23. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila.
Kretzschmar D; Tschäpe J; Bettencourt Da Cruz A; Asan E; Poeck B; Strauss R; Pflugfelder GO
Glia; 2005 Jan; 49(1):59-72. PubMed ID: 15390099
[TBL] [Abstract][Full Text] [Related]
24. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
25. SUMOylation substrates in neuronal intranuclear inclusion disease.
Takahashi-Fujigasaki J; Arai K; Funata N; Fujigasaki H
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):92-100. PubMed ID: 16409557
[TBL] [Abstract][Full Text] [Related]
26. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
Fu L; Gao YS; Sztul E
Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
[TBL] [Abstract][Full Text] [Related]
28. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
[TBL] [Abstract][Full Text] [Related]
29. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.
Pountney DL; Huang Y; Burns RJ; Haan E; Thompson PD; Blumbergs PC; Gai WP
Exp Neurol; 2003 Nov; 184(1):436-46. PubMed ID: 14637113
[TBL] [Abstract][Full Text] [Related]
30. Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.
Lieberman AP; Trojanowski JQ; Leonard DG; Chen KL; Barnett JL; Leverenz JB; Bird TD; Robitaille Y; Malandrini A; Fischbeck KH
Ann Neurol; 1999 Aug; 46(2):271-3. PubMed ID: 10443897
[TBL] [Abstract][Full Text] [Related]
31. [INTRANUCLEAR UBIQUITIN-IMMUNOPOSITIVE STRUCTURES OF THE HUMAN SUBSTANTIA NIGRA NEURONS].
Grigoriev IP; Korzhevskii DE; Sukhorukova EG; Gusel'nikova VV; Kirik OV
Tsitologiia; 2015; 57(11):780-7. PubMed ID: 27012092
[TBL] [Abstract][Full Text] [Related]
32. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal.
Riley BE; Zoghbi HY; Orr HT
J Biol Chem; 2005 Jun; 280(23):21942-8. PubMed ID: 15824120
[TBL] [Abstract][Full Text] [Related]
33. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
[TBL] [Abstract][Full Text] [Related]
34. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
[TBL] [Abstract][Full Text] [Related]
35. Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD.
Jana NR; Nukina N
Neurotox Res; 2004; 6(7-8):523-33. PubMed ID: 15639784
[TBL] [Abstract][Full Text] [Related]
36. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study.
Koyano S; Uchihara T; Fujigasaki H; Nakamura A; Yagishita S; Iwabuchi K
Neurosci Lett; 1999 Oct; 273(2):117-20. PubMed ID: 10505630
[TBL] [Abstract][Full Text] [Related]
37. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
38. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
Furusho K; Yoshizawa T; Shoji S
Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions.
Nagaoka U; Kim K; Jana NR; Doi H; Maruyama M; Mitsui K; Oyama F; Nukina N
J Neurochem; 2004 Oct; 91(1):57-68. PubMed ID: 15379887
[TBL] [Abstract][Full Text] [Related]
40. Intranuclear inclusions and the ubiquitin-proteasome pathway: digestion of a red herring?
Floyd JA; Hamilton BA
Neuron; 1999 Dec; 24(4):765-6. PubMed ID: 10624938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
